Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders

British Journal of Surgery

Volumn 99, Issue 1, 2012, Pages 100-103

  Pournaras, D J ^a,b   Aasheim, E T ^a,c   Sovik T T ^c   Andrews, R ^b   Mahon, D ^b   Welbourn, R ^b   Olbers, T ^a   Le Roux, C W ^a  

^a CHARING CROSS HOSPITAL   (United Kingdom)

^b MUSGROVE PARK HOSPITAL   (United Kingdom)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; GLYCOSYLATED HEMOGLOBIN; HEMOGLOBIN A1C PROTEIN, HUMAN; INSULIN;

ADULT; AGED; ARTICLE; BLOOD; CLINICAL TRIAL; FEMALE; GASTRECTOMY; GASTROPLASTY; GLUCOSE BLOOD LEVEL; HUMAN; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; MULTICENTER STUDY; NON INSULIN DEPENDENT DIABETES MELLITUS; NORWAY; PROSPECTIVE STUDY; RETROSPECTIVE STUDY; STOMACH BYPASS; TIME; TREATMENT OUTCOME; UNITED KINGDOM;

ADULT; AGED; BIOLOGICAL MARKERS; BLOOD GLUCOSE; DIABETES MELLITUS, TYPE 2; FEMALE; GASTRECTOMY; GASTRIC BYPASS; GASTROPLASTY; GREAT BRITAIN; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; MALE; MIDDLE AGED; NORWAY; PROSPECTIVE STUDIES; RETROSPECTIVE STUDIES; TIME FACTORS; TREATMENT OUTCOME;

EID: 82955195922     PISSN: 00071323     EISSN: 13652168     Source Type: Journal    
DOI: 10.1002/bjs.7704     Document Type: Article

References (15)

1. Buse JB, Caprio S, Cefalu WT, Ceriello A, Del Prato S, Inzucchi SE, et al., How do we define cure of diabetes? Diabetes Care 2009; 32: 2133-2135.
2. Buchwald H, Estok R, Fahrbach K, Banel D, Jensen MD, Pories WJ, et al., Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis. Am J Med 2009; 122: 248-256.
3. Buchwald H, Avidor Y, Braunwald E, Jensen MD, Pories W, Fahrbach K, et al., Bariatric surgery: a systematic review and meta-analysis. JAMA 2004; 292: 1724-1737. (Pubitemid 39346675)
4. Søvik TT, Irandoust B, Birkeland KI, Aasheim ET, Schou CF, Kristinsson J, et al., [Type 2 diabetes and metabolic syndrome before and after gastric bypass.] Tidsskr Nor Laegeforen 2010; 130: 1347-1350.
5. Schauer PR, Burguera B, Ikramuddin S, Cottam D, Gourash W, Hamad G, et al., Effect of laparoscopic Roux-en $\font\ss=cmss10 scaled 1000 \hbox{Y}$ gastric bypass on type 2 diabetes mellitus. Ann Surg 2003; 238: 467-484.
6. Pournaras DJ, Osborne A, Hawkins SC, Vincent RP, Mahon D, Ewings P, et al., Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes. Ann Surg 2010; 252: 966-971.
7. Abbatini F, Rizzello M, Casella G, Alessandri G, Capoccia D, Leonetti F, et al., Long-term effects of laparoscopic sleeve gastrectomy, gastric bypass, and adjustable gastric banding on type 2 diabetes. Surg Endosc 2010; 24: 1005-1010.
8. Dixon JB, O'Brien PE, Playfair J, Chapman L, Schachter LM, Skinner S, et al., Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial. JAMA 2008; 299: 316-323. (Pubitemid 351159368)
9. Rubino F, Kaplan LM, Schauer PR, Cummings DE,; Diabetes Surgery Summit Delegates. The Diabetes Surgery Summit consensus conference: recommendations for the evaluation and use of gastrointestinal surgery to treat type 2 diabetes mellitus. Ann Surg 2010; 251: 399-405.
10. Greve JW, Rubino F,. Bariatric surgery for metabolic disorders. Br J Surg 2008; 95: 1313-1314.
11. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 1998; 352: 837-853.
12. Ray KK, Seshasai SR, Wijesuriya S, Sivakumaran R, Nethercott S, Preiss D, et al., Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials. Lancet 2009; 373: 1765-1772.
13. Welbourn R, Fiennes A, Kinsman R, Walton P,. The National Bariatric Surgery Registry: First Registry Report to March 2010. Dendrite Clinical Systems: Henley-on-Thames, 2011.
14. Vague P, Nguyen L,. Rationale and methods for the estimation of insulin secretion in a given patient: from research to clinical practice. Diabetes 2002; 51 (Suppl 1): S240-S244. (Pubitemid 34761522)
15. Sacks DB, Arnold M, Bakris GL, Bruns DE, Horvath AR, Kirkman MS, et al., Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Diabetes Care 2011; 34: e61-e99.